Glucose Regulation — Insulin, Glucagon and the Pancreatic Feedback System
When you sprint 400 metres, your muscles burn glucose ~20 times faster than at rest — fast enough to empty your blood's entire glucose supply in about 30 seconds. Yet your blood glucose barely moves. Two opposing hormones and one remarkable organ keep it pinned near 5 mmol/L, and when that system fails, the result is diabetes.
Practise this lesson
Four printable worksheets that build from the foundations up to exam-style questions — start at whatever level suits you.
The endocrine system — hormones coordinate glucose regulation through the bloodstream
When you sprint 400 metres, your leg muscles burn through glucose at a rate roughly 20 times higher than at rest. Your blood only contains about 5 grams of dissolved glucose at any moment — enough to fuel about 30 seconds of sprinting at that rate.
Yet in a healthy person, blood glucose during a 400 m sprint barely drops below 4 mmol/L. It might dip slightly, then stabilise — and within minutes of finishing, it returns to normal.
Before reading on, answer these two questions:
Q1: If muscles are consuming glucose faster than you are eating, where is the replacement glucose coming from? Name the organ you think is most likely involved.
Q2: After a large meal, blood glucose could rise to 8–10 mmol/L if nothing corrected it. What do you think the body does with that excess glucose, and which hormone do you think is involved?
Know
- The role of alpha cells (glucagon) and beta cells (insulin) in the islets of Langerhans
- The complete pathway for responding to high blood glucose (insulin pathway)
- The complete pathway for responding to low blood glucose (glucagon pathway)
- The role of the liver in glycogenesis and glycogenolysis
- The difference between Type 1 and Type 2 diabetes at the mechanism level
Understand
- Why the pancreas must run two opposing hormones simultaneously to maintain fine control
- Why the liver — not the pancreas — is the primary effector in glucose regulation
- Why Type 1 and Type 2 diabetes are fundamentally different diseases despite similar symptoms
- How failure of glucose homeostasis produces the specific complications of diabetes
Can Do
- Draw and label the complete insulin and glucagon feedback pathways from stimulus to response
- Identify insulin, glucagon, glycogenesis, and glycogenolysis in an exam scenario
- Distinguish Type 1 from Type 2 diabetes using mechanism-level language
- Apply the stimulus-response model to a glucose regulation scenario
Core Content
The same organ detects the stimulus and secretes the hormone — which makes the pathway cleaner
In temperature regulation (L02), the receptor (thermoreceptors) and control centre (hypothalamus) were separate. Glucose regulation is slightly different — the pancreatic islet cells function as both receptor and effector in the same organ, detecting blood glucose directly and secreting the corrective hormone without a separate signal-processing step.
Glucose regulation feedback loop showing insulin and glucagon action
Comparison of Type 1 and Type 2 diabetes
The pancreas is a dual-function organ: most of it is exocrine (secreting digestive enzymes into the small intestine), but scattered throughout the tissue are roughly one million small clusters of endocrine cells called the Islets of Langerhans. Two cell types in the islets are critical for glucose homeostasis:
- Beta cells detect rising blood glucose concentrations and secrete insulin directly into the bloodstream. They are simultaneously the receptor (they sense glucose) and the secretory unit (they release the hormone).
- Alpha cells detect falling blood glucose concentrations and secrete glucagon directly into the bloodstream. They operate in opposition to beta cells.
Both hormones travel through the blood to their primary target: the liver. This makes the liver the key effector in glucose homeostasis — it is the organ that actually changes blood glucose concentration in response to these hormonal signals. The liver can act as a glucose sink (storing excess as glycogen during high blood glucose) and a glucose source (releasing stored glucose during low blood glucose).
What to write in your book
- Islets of Langerhans (pancreas) hold beta cells (insulin) and alpha cells (glucagon).
- Beta cells = receptor + secretory unit for HIGH glucose; alpha cells for LOW glucose.
- Both hormones target the liver — the key effector.
- Cue: Beta, Blood glucose too high, Bring it down (insulin).
Which pancreatic cells secrete insulin when blood glucose is high?
Two opposing negative feedback loops operating simultaneously to oscillate glucose around ~5 mmol/L
Glucose homeostasis is maintained by two opposing negative feedback loops that operate simultaneously — one activated when glucose is too high, one when it is too low. Together they produce continuous oscillation around the set point of approximately 5 mmol/L.
When Blood Glucose Is HIGH (e.g. after a meal)
Stimulus: blood glucose rises above ~6 mmol/L
Beta cells in islets of Langerhans detect high glucose → secrete insulin into bloodstream
Insulin travels to body cells → cells increase uptake of glucose (GLUT4 transporters move to membrane)
Insulin travels to liver → liver converts glucose to glycogen (glycogenesis) and stores it
Blood glucose falls back toward ~5 mmol/L → beta cells detect normalisation → insulin secretion decreases (self-limiting negative feedback)
When Blood Glucose Is LOW (e.g. during exercise, fasting)
Stimulus: blood glucose falls below ~4 mmol/L
Alpha cells in islets of Langerhans detect low glucose → secrete glucagon into bloodstream
Glucagon travels to the liver → liver breaks down stored glycogen to glucose (glycogenolysis)
Glucose released from liver into the bloodstream → blood glucose rises toward ~5 mmol/L
Alpha cells detect normalising glucose → glucagon secretion decreases (self-limiting negative feedback)
Why two hormones instead of one?
A single hormone that simply 'corrected' glucose would create sluggish control — the response would lag too far behind the stimulus, resulting in large swings. Two opposing hormones provide faster, more precise fine-tuning: as blood glucose rises from a meal, insulin rises rapidly; before glucose has fully fallen back to the set point, glucagon is already suppressed. This push-pull system maintains tighter oscillation than a single-hormone system could achieve.
This is analogous to how a car's cruise control uses both throttle and brake simultaneously to maintain a steady speed on varying terrain — not just one input in response to deviation.
What to write in your book
- HIGH glucose → beta cells → insulin → cells take up glucose + liver glycogenesis → glucose falls.
- LOW glucose → alpha cells → glucagon → liver glycogenolysis → glucose released → glucose rises.
- Two opposing hormones = faster, tighter push-pull control than one could give.
- Both loops are self-limiting negative feedback.
When blood glucose falls, alpha cells release _____, which triggers glycogenolysis in the liver.
The liver actually changes blood glucose; the pancreas only gives the instruction
The pancreatic islet cells detect and signal — but the liver is the structure that physically changes blood glucose concentration. Without a functioning liver, neither insulin nor glucagon can maintain blood glucose homeostasis regardless of how much hormone is present.
The liver receives blood directly from the gastrointestinal tract via the portal vein, making it the first organ to encounter glucose absorbed from digested food. This positioning is not coincidental — it allows the liver to act as a first-pass buffer, absorbing a large fraction of post-meal glucose before it reaches systemic circulation.
Glycogenesis — storing glucose when insulin is high
When insulin levels are elevated (post-meal), the liver converts excess blood glucose into glycogen — a branched polymer of glucose that can be compactly stored. A healthy liver can store approximately 100 g of glycogen, equivalent to roughly 400 kcal. This stored glycogen is the rapid-release glucose reserve that prevents hypoglycaemia during fasting or exercise.
Glycogenolysis — releasing glucose when glucagon is high
When glucagon levels are elevated (fasting, exercise), the liver breaks down stored glycogen back into glucose and releases it into the bloodstream. This process can sustain blood glucose for approximately 12–16 hours of fasting — after which the liver begins gluconeogenesis (synthesising new glucose from amino acids and glycerol), but that is beyond the scope of this lesson.
Why the answer to Think First Q1 is the liver
During a 400 m sprint, blood glucose dips slightly, triggering glucagon release. The liver immediately begins glycogenolysis — releasing stored glucose into the blood. This is why blood glucose stays stable: the liver is continuously releasing glucose to match the rate at which muscles are consuming it. The liver is not making new glucose — it is releasing its stored glycogen. This is why athletes 'carb load' before endurance events: they are maximising liver (and muscle) glycogen stores to delay glucose depletion.
What to write in your book
- Liver = key effector; receives gut blood via the portal vein (first-pass buffer).
- Glycogenesis (insulin high): glucose → glycogen, stored (~100 g in liver).
- Glycogenolysis (glucagon high): glycogen → glucose, released; sustains ~12–16 h fasting.
- Stable glucose during exercise = liver glycogenolysis matching muscle demand.
The pancreas is the effector that physically changes blood glucose concentration.
Insulin is secreted by beta cells in the pancreas and lowers blood glucose by promoting cellular uptake and glycogen storage.
Glucagon is released when blood glucose is high and stimulates glycogen synthesis in the liver.
Two very different mechanisms of failure producing similar symptoms — the distinction matters for treatment
Diabetes mellitus is the collective name for conditions in which blood glucose homeostasis fails — either because insulin cannot be produced, or because target cells no longer respond to it adequately. Both outcomes produce chronic hyperglycaemia, but the underlying mechanism and therefore the treatment approach differ fundamentally.
| Feature | Type 1 Diabetes | Type 2 Diabetes |
|---|---|---|
| Primary cause | Autoimmune destruction of pancreatic beta cells → no insulin produced | Insulin resistance in target cells → inadequate glucose uptake despite insulin present |
| Insulin levels | Very low or absent | Initially normal or high; beta cells may eventually exhaust and decline |
| Which part of pathway fails | Step 2 — beta cells cannot secrete insulin (no hormone) | Step 3 — cells do not respond to insulin (no response to hormone) |
| Homeostatic consequence | High blood glucose cannot be corrected — chronic hyperglycaemia | High blood glucose inadequately corrected — chronic hyperglycaemia |
| Age of typical onset | Often childhood or adolescence (but can occur at any age) | Typically adult onset (but increasingly adolescent) |
| Risk factors | Genetic predisposition; autoimmune triggers | Obesity, physical inactivity, diet, genetic predisposition, age |
| Management | Insulin injections or pump (cannot be managed without exogenous insulin) | Lifestyle modification, metformin, other medications; insulin only in late stages |
Why chronic hyperglycaemia causes complications
When blood glucose remains chronically elevated above ~7 mmol/L, glucose molecules attach non-enzymatically to proteins throughout the body — a process called glycation. Glycated proteins in blood vessel walls cause them to thicken and lose elasticity, progressively narrowing capillaries. This vascular damage produces the characteristic long-term complications of diabetes: retinopathy (damage to retinal blood vessels → blindness), nephropathy (damage to glomerular capillaries → kidney failure), neuropathy (damage to nerve supply capillaries → loss of sensation, particularly in feet), and accelerated cardiovascular disease.
All of these complications follow from a single homeostatic failure — chronic blood glucose exceeding the tolerance range — which is why early detection and blood glucose management are the central goals of diabetes care.
What to write in your book
- Type 1: autoimmune destruction of beta cells → no insulin (pathway step 2 fails).
- Type 2: insulin resistance → cells don't respond (pathway step 3 fails).
- Both → chronic hyperglycaemia.
- Complications via glycation of vessel walls: retinopathy, nephropathy, neuropathy, CVD.
What is the key mechanistic difference between Type 1 and Type 2 diabetes?
Insulin, Glucagon, or Neither?
For each statement, identify insulin (I), glucagon (G), both (B), or neither (N) and justify in one sentence linking to mechanism.
- Secreted by alpha cells in the islets of Langerhans.
- Signals the liver to convert glycogen to glucose.
- Secretion increases after a large carbohydrate-rich meal.
- Travels through the bloodstream to its primary target organ. (Name the primary target for each.)
- A person with Type 1 diabetes who misses their insulin injection will have almost none of this hormone in their blood. (What happens to the other hormone in its absence?)
Tracing the Pathway Through a Scenario
Read each scenario carefully and answer all parts using precise biological terminology from this lesson.
- A person eats a bowl of pasta (high carbohydrate). Within 30 minutes, their blood glucose reaches 9.2 mmol/L. Two hours later it has returned to 5.1 mmol/L without them eating anything else. Trace the complete negative feedback pathway that produced this correction, naming: the stimulus, receptor, hormone secreted, primary effector organ, process occurring in the effector, and the response. Then state why this is negative feedback.
- A Type 2 diabetic eats the same bowl of pasta. Their blood glucose also reaches 9.2 mmol/L. Two hours later it is still at 8.4 mmol/L. (a) Which step of the normal pathway has failed? (b) Is insulin present in this person's blood? Why is it not working? (c) What is the name of the underlying defect? (d) Why does the glucose remain elevated rather than continuing to rise indefinitely?
A continuous glucose monitor (CGM) is a small device worn on the arm or abdomen by people with diabetes. A tiny sensor sits just beneath the skin and measures interstitial glucose concentration every 5 minutes, sending the data wirelessly to a smartphone app. When blood glucose rises above a set threshold, the app alerts the user to take insulin. When it falls below a lower threshold, it alerts them to consume carbohydrate.
In effect, the CGM is replacing the receptor and control centre functions that the islets of Langerhans can no longer perform adequately — constantly monitoring the key homeostatic variable and triggering a corrective response when it deviates. The human (or in closed-loop 'artificial pancreas' systems, an automated insulin pump) acts as the effector.
This technology directly maps onto the stimulus-response model from L01: CGM sensor = receptor; algorithm/app = control centre; insulin pump or human decision = effector; insulin injection or carbohydrate intake = response. Understanding the biology of glucose homeostasis allows you to understand exactly what each component of the technology is doing and why.
Insulin Pathway (HIGH glucose)
- Blood glucose high → beta cells detect
- Insulin secreted → cells take up glucose
- Liver: glycogenesis (glucose → glycogen)
- Blood glucose falls → insulin decreases (negative feedback)
Glucagon Pathway (LOW glucose)
- Blood glucose low → alpha cells detect
- Glucagon secreted → travels to liver
- Liver: glycogenolysis (glycogen → glucose)
- Glucose released → blood glucose rises (negative feedback)
Cell Types to Remember
- Beta cells → insulin (high glucose)
- Alpha cells → glucagon (low glucose)
- Both in islets of Langerhans (pancreas)
- Liver = key effector (not pancreas)
Type 1 vs Type 2 Diabetes
- Type 1: beta cells destroyed → no insulin
- Type 2: cells resistant to insulin → inadequate uptake
- Both → chronic hyperglycaemia
- Complications: glycation → retinopathy, nephropathy, neuropathy
A fresh set drawn from this lesson's question bank — feedback shown immediately. +5 XP per correct · +25 XP all correct
Pick your answer, then rate your confidence — that tells the system what to drill next.
ApplyBand 4(5 marks) 1. Describe the complete negative feedback pathway that returns blood glucose to its normal range after a meal. Name the stimulus, the receptor cells, the hormone secreted, the effector organ, the process occurring in the effector, and the response. State why this is an example of negative feedback.
AnalyseBand 4–5(5 marks) 2. Compare the mechanisms by which Type 1 and Type 2 diabetes disrupt glucose homeostasis. Identify which component of the homeostatic pathway fails in each condition and explain why both result in chronic hyperglycaemia despite different underlying mechanisms.
EvaluateBand 5–6(5 marks) 3. A continuous glucose monitor (CGM) measures blood glucose every 5 minutes and alerts when glucose is outside the normal range. Identify which components of the normal glucose homeostatic system the CGM replaces, which it cannot replace, and explain what additional technology would be needed to create a fully automated glucose homeostasis system.
Show all answers
Multiple choice
MC answers and full explanations are shown inline as you complete each question. Use the retry button to attempt a fresh set from the lesson bank.
Activity 1 — Insulin, Glucagon, or Neither?
1. G — Glucagon is secreted by alpha cells. Insulin is secreted by beta cells. Both are in the islets of Langerhans.
2. G — Glucagon signals the liver to perform glycogenolysis — the breakdown of stored glycogen into glucose, which is then released into the bloodstream. Insulin does the opposite: glycogenesis (glucose → glycogen).
3. I — A large carbohydrate meal causes blood glucose to rise. Rising glucose is the stimulus that triggers beta cells to secrete insulin; glucagon secretion would decrease.
4. B (Both) — Both insulin and glucagon are peptide hormones secreted into the bloodstream and travel to target organs. Insulin's primary targets are liver and body cells (muscle, adipose); glucagon's primary target is the liver.
5. I (Insulin) — A Type 1 diabetic who misses their injection has negligible insulin because beta cells are destroyed. Without insulin signalling glucose uptake, blood glucose rises. Glucagon (from intact alpha cells) may be elevated, worsening hyperglycaemia by continuing glycogenolysis — one reason diabetic ketoacidosis develops rapidly in Type 1 diabetes.
Activity 2 — Pathway Scenarios
1. Post-meal correction: Stimulus: blood glucose rises to 9.2 mmol/L (above the ~6 mmol/L upper tolerance limit). Receptor: beta cells in the islets of Langerhans detect the elevated glucose directly. Hormone: insulin, secreted by beta cells into the bloodstream. Primary effector organ: the liver. Process: glycogenesis — insulin signals liver cells to convert excess glucose into glycogen for storage; body cells also increase glucose uptake (GLUT4). Response: blood glucose falls to 5.1 mmol/L. Negative feedback: the response (glucose removal → falling glucose) opposes the stimulus (rising glucose), returning the variable to its set point; as glucose normalises, insulin secretion falls (self-limiting).
2. Type 2 diabetic: (a) Step 3 has failed — target cells do not respond adequately to insulin. (b) Yes, insulin is present (often normal/elevated early in Type 2 as the pancreas compensates); it is not working because target cells have reduced sensitivity (insulin resistance) — receptors do not respond effectively, so GLUT4 transporters are not mobilised and uptake is inadequate. (c) The defect is insulin resistance. (d) Glucose does not rise indefinitely because some uptake still occurs via insulin-independent pathways, the kidneys excrete glucose above the renal threshold (~10 mmol/L), and partial insulin sensitivity provides some (insufficient) correction.
Short Answer Model Answers
SA1 (5 marks): Stimulus: blood glucose rises above ~6 mmol/L after a meal [1]. Receptor: beta cells in the islets of Langerhans directly detect the elevated glucose [1]. Hormone: insulin, secreted by beta cells into the bloodstream [1]. Effector organ: the liver (primary); body cells also respond. Process: glycogenesis — the liver converts excess glucose into glycogen for storage; body cells increase glucose uptake via GLUT4 mobilisation [1]. Response: blood glucose falls toward ~5 mmol/L. Negative feedback: the response (glucose removal → falling glucose) opposes the stimulus (rising glucose), returning the variable to its set point; as glucose normalises beta cells reduce insulin secretion (self-limiting) [1].
SA2 (5 marks): Type 1: the receptor/secretory step fails — autoimmune destruction eliminates functional beta cells, so no insulin is produced; without insulin there is no signal for glucose uptake or glycogenesis, so glucose rises after eating and cannot be corrected [2]. Type 2: the effector-response step fails — insulin is produced (signalling is intact) but target cells have reduced sensitivity (insulin resistance); insulin binds but triggers a diminished response, so uptake and glycogenesis are inadequate [2]. Both produce chronic hyperglycaemia because in both cases blood glucose cannot be returned to the tolerance range after meals — the loop either has no signal (Type 1) or an inadequate effector response (Type 2); the homeostatic outcome (blood glucose chronically above set point) is identical [1].
SA3 (5 marks): The CGM replaces the receptor function — it continuously detects blood glucose (the homeostatic variable) and identifies deviation from the tolerance range, as alpha/beta cells do; it also partially replaces the control centre by processing the reading and deciding a corrective response is needed (the alert) [2]. The CGM cannot replace the effector — it cannot physically change blood glucose; it provides information but no correction. In the body, the effector (liver + body cells) changes glucose via glycogenesis/glycogenolysis; the CGM does neither [2]. To make the system fully automated, an automated insulin pump linked to the CGM ('closed-loop' / 'artificial pancreas') is required — the pump acts as the effector, delivering insulin (the response) in real time based on the CGM reading, closing the feedback loop without human intervention [1].
Five timed questions on insulin, glucagon, the liver and diabetes. Beat the boss to bank a tier — gold (perfect + fast), silver (80%+), or bronze (cleared).
⚔ Enter the arenaDefend your ship by blasting the correct answers for Glucose Regulation. Scores count toward the Asteroid Blaster leaderboard.
☄️ Play Asteroid Blaster →Rapid-fire questions on insulin, glucagon and the pancreatic feedback system. Pool: lessons 1–3.
Return to your Think First predictions at the start of this lesson.
- Q1 — source of glucose during exercise: Did you identify the liver? Mechanism: glucagon → glycogenolysis → glucose released from liver → blood glucose stabilised.
- Q2 — dealing with excess glucose post-meal: The hormone is insulin, and the process is glycogenesis — the liver converts excess glucose to stored glycogen.
- Write one sentence explaining why the liver — not the pancreas — is the key effector in glucose homeostasis.